MedPath

Examining the Effects of a Remote Pulmonary Rehabilitation Program in the Severe Asthma Population.

Not Applicable
Not yet recruiting
Conditions
Asthma
Interventions
Behavioral: Pulmonary rehab program
Behavioral: Placebo
Registration Number
NCT06150300
Lead Sponsor
University of Saskatchewan
Brief Summary

This is a randomized control trial evaluating the effect of a novel mobile application-delivered pulmonary rehabilitation program in adult severe asthma patients. The intervention will include eight weeks of exercise videos that progress in difficulty, as well as asthma-specific educational content. The primary outcome measure is change in functional exercise capacity as measured by six-minute walk distance. Secondary outcome measures will include evaluation of overall feasibility, and change in CPET parameters such as VO2max. Change in asthma control questionnaire (ACQ), asthma quality of life questionnaire (AQLQ) and PRAISE self-efficacy score will also be evaluated.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
34
Inclusion Criteria
  • Adults aged 18 years and older with a diagnosis of asthma by a respirologist. They must have severe disease defined by GINA severity classification. Participants must have access to a smartphone or internet browser to allow access to study content.
Exclusion Criteria
  • Exclusion criteria include comorbid cardiopulmonary or musculoskeletal conditions that may impact exercise tolerance in accordance with the American Thoracic Society CPET guidelines

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Physical activity interventionPulmonary rehab program8 week virtual pulmonary rehab program including breathing exercises and educational messages.
PlaceboPlaceboBreathing exercises and educational messages
Primary Outcome Measures
NameTimeMethod
CPETAfter 8 weeks of intervention

VO2max

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath